U.S. authorizes Merck pill as second at-home COVID-19 treatment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St futures slide as rising oil, yields dampen mood
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
| Merck & Co. (NYSE: MRK) | Delayed: 142.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $142.79 | 52 Week High | $65.46 | |||
| Open | $142.79 | 52 Week Low | $47.97 | |||
| Day High | $142.79 | P/E | 97.14 | |||
| Day Low | $142.79 | EPS | $1.47 | |||
| Volume | 10,093 | |||||
